403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Oncolytics Biotech Inc
(MENAFN- Baystreet) 10:55 AM EST - Oncolytics Biotech Inc: Announced new durability data in metastatic colorectal cancer, demonstrating meaningful and sustained clinical benefit in patients with RAS-mutant, microsatellite-stable disease. Oncolytics Biotech Inc
shares N are trading up $0.08 at $0.95.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment